The enzyme ADP-ribosyl (ADPR) cyclase plays a significant role in mediating increases in renal afferent arteriolar cytosolic calcium concentration ([Ca 2ϩ ]i) in vitro and renal vasoconstriction in vivo. ADPR cyclase produces cyclic ADP ribose, a second messenger that contributes importantly to ryanodine receptor-mediated Ca 2ϩ mobilization in renal vascular responses to several vasoconstrictors. Recent studies in nonrenal vascular smooth muscle cells (VSMC) have shown that nicotinic acid adenine dinucleotide phosphate (NAADP), another second messenger generated by ADPR cyclase, may contribute to Ca 2ϩ signaling. We tested the hypothesis that a Ca 2ϩ signaling pathway involving NAADP receptors participates in afferent arteriolar [Ca 2ϩ ]i responses to the G protein-coupled receptor agonists endothelin-1 (ET-1) and norepinephrine (NE). To test this, we isolated rat renal afferent arterioles and measured [Ca 2ϩ ]I using fura-2 fluorescence. We compared peak [Ca 2ϩ ]i increases stimulated by ET-1 and NE in the presence and absence of inhibitors of acidic organelledependent Ca 2ϩ signaling and NAADP receptors. Vacuolar H ϩ -ATPase inhibitors bafilomycin A1 and concanamycin A , disruptors of pH and Ca 2ϩ stores of lysosomes and other acidic organelles, individually antagonized [Ca 2ϩ ]i responses to ET-1 and NE by 40 -50% (P Ͻ 0.05). The recently discovered NAADP receptor inhibitor Ned-19 attenuated [Ca 2ϩ ]i responses to ET-1 or NE by 60 -70% (P Ͻ 0.05). We conclude that NAADP receptors contribute to both ET-1-and NE-induced [Ca 2ϩ ]i responses in afferent arterioles, an effect likely dependent on acidic vesicle, possibly involving lysosome, signaling in VSMC in the renal microcirculation. 
RENAL BLOOD FLOW (RBF) and glomerular filtration rate (GFR) are regulated by afferent arteriolar resistance as dictated by the balance between vasodilator and vasoconstrictor factors. In turn, the renal microcirculation affects Na ϩ and water excretion, extracellular fluid volume, and systemic arterial pressure (AP). (1) . Cytosolic Ca 2ϩ concentration [Ca 2ϩ ] i in endothelial and vascular smooth muscle cells (VSMC) is central to the regulation of the overall contractile state of resistance arterioles. Many local and circulating vasoactive agents exert their effects by influencing [Ca 2ϩ ] i in either cell type. In endothelial cells, [Ca 2ϩ ] i activates endothelial nitric oxide synthase (eNOS) and production of the vasodilator NO as well as PLA 2 and arachidonic acid metabolites. In VSMC, [Ca 2ϩ ] i activates myosin light chain kinase, leading to phosphorylation of myosin fibers and vessel contraction. Elucidating mechanisms affecting Ca 2ϩ signaling in glomerular arterioles is therefore essential to a comprehensive understanding of basic function of the renal microcirculation in health and disease.
Afferent arteriolar [Ca 2ϩ ] i is generally kept low (ϳ100 nM) in an environment of high extracellular [Ca 2ϩ ] (ϳ1 mM). High [Ca 2ϩ ] is maintained in the sarcoplasmic reticulum (SR), mitochondria, and lysosomal and endo/exocytic vesicles by the sarco(endo)plasmic reticular Ca 2ϩ -ATPase (SERCA), mitochondrial Ca 2ϩ uniporter, and vacuolar H ϩ -ATPase, respectively (1, 33) . [Ca 2ϩ ] i is regulated by a combination of Ca 2ϩ entry through channels in the plasma membrane and Ca 2ϩ mobilization or release from SR stores with apparent agonist/ stimulus specificity. Ca 2ϩ mobilization from other intercellular stores is less well characterized.
Recent in vitro evidence from afferent arterioles as well as coronary and pulmonary arterial VSMC indicates that the enzyme ADP-ribosyl cyclases (ADPR cyclases) regulate ryanodine receptor (RyR)-mediated SR Ca 2ϩ release to cause global increases in [Ca 2ϩ ] i and contraction (13, 22, 44) . Importantly, animal studies indicate that this novel second messenger system plays a major role in increasing renal vascular resistance to the vasoconstrictors angiotensin II (ANG II), endothelin-1 (ET-1), and norepinephrine (NE) (36, 37) . ADPR cyclases in the sea hare (Aplysia californica) and mammals produce two second messengers: cyclic ADP ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) (3). cADPR is produced by plasma membrane-bound ADPR cyclase at relatively neutral physiological pH. NAADP, on the other hand, is primarily generated at very low pH such as that found in lysosomal and endo/exocytic vesicles (16, 41) . Whereas NAADP may be generated by nonenzymatic means, the ADPR cyclase from the A. californica and the mammalian ADPR cyclase CD38 are the only enzymes currently known to produce NAADP (19, 25) . Recently, NAADP has been shown to elicit Ca 2ϩ release from reserve granules in sea urchin eggs (5) and acidic organelles, possibly lysosomes, in mammalian cells such as pancreatic acinar cells and pulmonary arterial VSMC (22, 23, 42) . It is currently thought that ADPR cyclases produce NAADP in acidic organelles, with NAADP binding to a receptor/channel, perhaps a transient receptor potential-mucolipid 1 (TRP-ML1) channel (45) , in the organelle membrane to allow exit of Ca 2ϩ into the cytosol in coronary and pulmonary VSMC (22) . The identity of which particular acidic organelle synthesizes NAADP is currently uncertain and has been hypothesized to be late endosome, lysosome, and/or exocytic vesicles (22, 23, 6) . Although such localized Ca 2ϩ release is not normally sufficient to produce a widespread global Ca 2ϩ response leading, for example, to vessel contraction, acidic organelles bearing NAADP-sensitive receptor/ channels appear to lie in close proximity to the SR to form a "trigger zone" with nearby RyR (apparently subtype 3, RyR3) on the SR of pulmonary VSMC (23 release from the SR. NAADP increases Ca 2ϩ release from mesangial cell microsomes, and NAADP increases [Ca 2ϩ ] i when administered in microbubbles to coronary VSMC or given by intracellular dialysis to pulmonary arterial VSMC (22, 43, 46) . Physiologically, NAADP production may be stimulated downstream of G protein-coupled receptor (GPCR) signaling, since Ca 2ϩ responses to the GPCR agonist ET-1 appear to be attenuated in the absence of functional vesicles (22, 46) . In testicular peritubular smooth muscle cells, ET-1-induced contraction depends in part on caveolae and NAADP (17) . No study to date has investigated whether endogenous NAADP participates in GPCR stimulation of [Ca 2ϩ ] i in a resistance arteriole in general or a renal afferent arteriole in particular.
In the current study, we tested the hypothesis that native NAADP contributes to the increase in [ 
METHODS
Sprague-Dawley rats were fed standard laboratory chow and given tap water ad libitum and were kept on a 12:12-h light-dark cycle. Animal protocols were approved by the Institutional Animal Care and Use Committee of the University of North Carolina at Chapel Hill.
Isolation of afferent arterioles. Afferent arterioles were harvested from a total of 62 rats (3.5-6 wk of age) obtained from our in-house breeding facility. Our standard magnet/sieving preparation was used to isolate resistance arterioles (13, 14, 15) . Briefly, animals were anesthetized by intraperitoneal injection of pentobarbital sodium (55 mg/kg). Through a midline incision, the aorta was clamped above the renal arteries and cannulated at the bifurcation of the common iliac arteries using a 23-gauge butterfly needle. Kidneys were perfused with ice-cold phosphate-buffered saline (PBS: 137 mM NaCl, 4.1 mM KCl, 0.66 mM KH 2PO4, 3.4 mM Na2HPO4, 2.5 mM NaHCO3, 1.0 mM MgCl2, and 5 mM glucose, pH 7.4) followed by magnetized microspheres (Spherotech, Libertyville , IL). Kidneys were removed, decapsulated, homogenized, and filtered through a number 120 sieve to remove tubules and glomeruli. Tissue was then treated with collagenase (type IV, 5-10 g/ml; Worthington, Lakewood, NJ) in a 50:50 mixture of Hanks' buffered salt solution (HBSS) and PBS (pH 7.38) containing 0.1% bovine serum albumin (BSA) at 37°C for 18 min. Arterioles were then loaded with fura-2 AM (2 M) in HBSS-PBS with 0.1% BSA for 55 min in the dark. Vessels were placed in a solution of HBSS-PBS and 1.1 mM CaCl 2 (pH 7.35) just before the start of the experiment.
Afferent arterioles were identified by diameter (Ͻ20 m) and morphology (8 -14) . Arterioles were attached to an interlobular artery. A single afferent arteriole was centered in the optical field so that only afferent arteriolar [Ca 2ϩ ]i was measured. Endothelial cells were present but had been shown to be unresponsive in this preparation to stimuli added to the external bathing solution (14) . As a result, [Ca 2ϩ ]i measurements were due only to changes in VSMC [Ca 2ϩ ]i. Arterioles were placed on slides pretreated with Cell Tak (BD Biosciences, San Jose, CA), placed in 20 l of PBS solution containing 1.1 mM CaCl 2, and excited at alternating wavelengths of 340 and 380 nm by using a Delta-Scan equipped with dual monochronometers and a chopper [Photon Technology International (PTI)] (13, 14, 15) . Signals were passed through an emission barrier filter (510-nm band pass), and fluorescence was detected by a photomultiplier tube. Signals were processed using an IBM-compatible Pentium computer and Felix software (PTI). [Ca 2ϩ ]i calibration was based on a 340-to 380-nm signal ratio and known [Ca 2ϩ ]i concentrations as previously described (8, 13, 14) . [Ca 2ϩ ]i was calculated using the equation
where R is the ratio of the 340-to 380-nm signal, Rmax is the ratio in the presence of Ca 2ϩ saturation, Rmin is the ratio in the presence of Ca 2ϩ -free buffer, and Sf/Sb is the 340-to 380-nm ratio in Ca 2ϩ -free buffer compared with a Ca 2ϩ -replete solution (8, 21) . Background was subtracted for each vessel. After a control baseline reading of at least 30 s, ET-1 or NE was added during continuous recording. In other arterioles, an inhibitor was added to the bath 1-2 min before stimulation with either ET-1 or NE. A vessel that did not respond to 40 mM KCl at the end of either the control or experimental period was discarded. KCl-induced changes in [Ca 2ϩ ]i in the presence of inhibitors served as a positive control to ensure maintenance of responsiveness at the end of an experiment. Peak responses were defined as the highest signal occurring within the first 30 s after agonist addition. Plateau responses were taken as the [Ca 2ϩ ]i recorded at 90 s after agonist addition. Reagents. Concentrations of agonists and inhibitors used were based on previously published observations and on occasion were altered slightly in preliminary experiments to obtain a maximum effect. They were as follows: ET- ] i following ET-1 stimulation was unaffected (52 Ϯ 27 vs. 51 Ϯ 18 nM, P Ͼ 0.9, Fig. 2 ] i produced by high KCl given after NE was unaltered by Ned-19 (P Ͼ 0.2, Fig. 6 ), suggesting an action of Ca 2ϩ mobilization rather than entry. Because Ned-19 attenuated the immediate peak [Ca 2ϩ ] i response to both ET-1 and NE, we conclude that NAADP receptors and related Ca 2ϩ release from acidic compartments contribute importantly to the most rapid afferent arteriolar [Ca 2ϩ ] i responses to these two GPCR agonists.
DISCUSSION
Our major novel observation is the contribution of the NAADP signaling pathway to GPCR-induced [Ca 2ϩ ] i responses in a true resistance arteriole Ͻ20 m in diameter, and the afferent arteriole of the renal microcirculation in particular. ] i responses to NE in isolated afferent arterioles. We We chose to study the effects of NAADP pathway inhibitors on Ca 2ϩ signaling initiated by NE and ET-1 activation of distinct GPCR classes. In all VSMC, alterations in [Ca 2ϩ ] i are a primary determinant of vascular tone. Arterial pressure and organ blood flow are therefore largely controlled by the actions of various regulators of VSMC [Ca 2ϩ ] I , including GPCR agonists (1). In afferent arterioles, renal nerves release NE to act on VSMC and produce vasoconstriction evidenced as decreases in RBF and GFR (18, 31) . Locally, endothelial cells release ET-1 to act on endothelial cells in an autocrine manner and on VSMC in a paracrine fashion (34) . Thus our results strongly suggest participation of acidic Ca 2ϩ stores and NAADP in the neural and autocrine/paracrine regulation of RBF and GFR, advancing an area ripe for future investigation.
We used three pharmacological inhibitors of various steps in the NAADP signaling pathway. Bafilomycin A1 and concanamycin A should have two effects: an increase in pH that leads to decreased production of NAADP by ADPR cyclases located in the membranes of acidic organelles (5, 24) It is important to note that the inhibitors used in our study, concanamycin A and bafilomycin A1, inhibit H ϩ and, subsequently, Ca 2ϩ uptake into all acidic organelles. Thus it is not clear which particular organelle is involved in mediating afferent arteriolar NE and ET-1 Ca 2ϩ responses. Likewise, other studies on coronary and pulmonary VSMC also have used general vacuolar ATPase inhibitors or lysotracker, a fluorescent dye that labels all acidic organelles (22, 23, 46) . Recent evidence obtained on sea urchin eggs suggests that the site of NAADP synthesis may be exocytic vesicles (6) . Future studies are required to determine the precise identity of this compartment in VSMC.
Noteworthy is the preferential inhibition of the antagonists on the initial peak vs. sustained plateau Ca 2ϩ responses. Peak responses to both NE and ET-1 were blunted significantly by all inhibitors tested. However, the ET-1-induced Ca 2ϩ plateau was not altered by any inhibitor. Apparent effects on plateaus during NE stimulation were more variable, on the other hand, affected by some inhibitors but not others. Application of a Ca 2ϩ free external solution to isolated rat interlobular arteries and afferent arterioles abolishes the plateau [Ca 2ϩ ] i response to NE but not the peak response (8, 32) (15, 36) . RyR appear to be localized adjacent to NAADP receptors in membranes of acidic organelles (22) and also are reported to reside near largeconductance Ca 2ϩ -activated K ϩ (BK Ca ) channels in the plasma membrane of VSMC (38) . The two products of ADPR cyclase may enhance the actions of one another as well. Although NAADP works in the manner described above, cADPR enhances RyR open probability, possibly by removing inhibitory FK506 binding proteins (35) . It is possible that, in this way, cADPR can amplify effects of NAADP to produce a larger [Ca 2ϩ ] i response such that the combined effect is greater than activation of a single second messenger. It is currently unknown whether cADPR and NAADP are produced by two distinct populations of ADPR cyclases or whether cADPR is produced at the plasma membrane followed by internalization of the same enzyme and subsequent production of NAADP.
Our understanding of precise interactions between these sources of ADPR cyclase metabolites and their relative roles in regulating [Ca 2ϩ ] i awaits future investigation. We found that resting baseline [Ca 2ϩ ] i is not altered during the initial 1-2 min of inhibition of vacuolar H ϩ -ATPase and/or NAADP receptors, suggesting that NAADP is likely not produced in sufficient amounts under our basal ex vivo conditions. In marked contrast, acute GPCR activation by ET-1 or NE stimulates ADPR cyclase production of NAADP in a manner similar to production of cyclic ADP-ribose, both of which enhance RyR-mediated Ca 2ϩ release. The TRP-ML1 channel is reported to function as a NAADP receptor in coronary arterial myocytes (45) . Future experiments should help determine whether NAADP is produced by some or all GPCR acting to increase [Ca 2ϩ ] i or Ca 2ϩ signaling elicited by other vasoconstrictor stimuli, e.g., pressure-induced myogenic response.
In summary, our novel findings provide insight into mechanisms mediating Ca 2ϩ signal transduction in a small-diameter resistance arteriole in the renal microcirculation. Our new evidence demonstrates that NAADP receptors contribute to GPCR-induced [Ca 2ϩ ] i changes in isolated rat afferent arterioles. This holds for GPCR acutely stimulated by either ET-1 or NE. Immediate peak responses to both agonists are markedly attenuated during pharmacological inhibition of the vacuolar H ϩ -ATPase and NAADP receptors. Our observations indicate major involvement of this NAADP second messenger pathway in ET-1-and NE-induced Ca 2ϩ signaling in renal arteriolar VSMC. This work advances our understanding of Ca 2ϩ signal transduction in a resistance arteriole such as the afferent arteriole and provides a rationale and background for future experiments investigating the importance of this ADPR cyclase/NAADP pathway in the regulation of renal hemodynamics and blood flow in other organs in health and disease.
